CADENCE PHARMACEUTICALS

cadence-pharmaceuticals-logo

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 2010 Cadence resubmitted a New Drug Application for its investigational product candidate, OFIRMEVTM (acetaminophen) injection for the treatment of pain and fever in adults and children. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date for OFIRMEV of November 4, 2010.
#People #Financial #Website #More

CADENCE PHARMACEUTICALS

Social Links:

linkedin

Linkedin

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2004-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.cadencepharm.com

Total Employee:
251+

Status:
Closed

Contact:
8584361401

Email Addresses:
[email protected]

Total Funding:
86.6 M USD

Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Proofpoint Symantec.cloud



Current Advisors List

frank-torti_image

Frank Torti Investor @ Cadence Pharmaceuticals
Board_member

brian-atwood_image

Brian Atwood Board Member @ Cadence Pharmaceuticals
Board_member

jim-blair_image

Jim Blair Board Member @ Cadence Pharmaceuticals
Board_member

michael-eagle_image

Michael Eagle Member of the Board of Directors @ Cadence Pharmaceuticals
Board_member

olav-bergheim_image

Olav Bergheim Board of Directors @ Cadence Pharmaceuticals
Board_member

Current Employees Featured

ted-schroeder_image

Ted Schroeder
Ted Schroeder President & CEO @ Cadence Pharmaceuticals
President & CEO

Founder


ted-schroeder_image

Ted Schroeder

Stock Details


Company's stock symbol is NASDAQ:CADX

Investors List

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - Cadence Pharmaceuticals

bay-city-capital_image

Bay City Capital

Bay City Capital investment in Post-IPO Equity - Cadence Pharmaceuticals

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Post-IPO Equity - Cadence Pharmaceuticals

venrock_image

Venrock

Venrock investment in Post-IPO Equity - Cadence Pharmaceuticals

domain-associates_image

Domain Associates

Domain Associates investment in Post-IPO Equity - Cadence Pharmaceuticals

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Post-IPO Equity - Cadence Pharmaceuticals

versant-ventures_image

Versant Ventures

Versant Ventures investment in Post-IPO Equity - Cadence Pharmaceuticals

bay-city-capital_image

Bay City Capital

Bay City Capital investment in Post-IPO Equity - Cadence Pharmaceuticals

Official Site Inspections

http://www.cadencepharm.com

  • Host name: cadencepharm.com
  • IP address: 146.214.96.246
  • Location: St Louis United States
  • Latitude: 38.6249
  • Longitude: -90.4496
  • Metro Code: 609
  • Timezone: America/Chicago
  • Postal: 63131

Loading ...

More informations about "Cadence Pharmaceuticals" on Search Engine

dfkcompany.com © 2022. All rights reserved